Join Ina Hassani from LiveGen as she reveals groundbreaking insights into how Outcome-Based Agreements (OBAs) are revolutionizing pharmaceutical access and innovation. Key highlights include: 535+ global outcome-based agreements analyzed, challenges in the Canadian healthcare market access, and strategies for accelerating patient access to breakthrough therapies.
In this must-watch presentation, discover:
✓ Why Canada lags in therapy reimbursement
✓ Global strategies for reducing healthcare uncertainty
✓ Key trends in market access negotiations
✓ Innovative approaches to sharing risk between manufacturers and payers
Want More In-Depth Market Access Insights? Visit our comprehensive content hub: https://www.marketaccesscanada.ca/
